STRIDES: A Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia

The STRIDES study will evaluate the safety and efficacy of SLS-005 (Trehalose Injection, 90.5 mg/mL for Intravenous Infusion) for the Treatment of Adults with Spinocerebellar Ataxia.

For SLS-005 Trehalose clinical study queries, please contact

For additional information, please reach out to the recruitment contacts provided on Identifier: NCT05490563

Full Text View -